e-learning
resources
Virtual 2020
Pre-Congress Content
Multidrug-resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tuberculosis in Estonia: a major impact of Russian MDR Mycobacterium tuberculosis Beijing B0/W148-cluster
A. Gerasimova (St. Petersburg, Russian Federation), A. Vyazovaya (St. Petersburg, Russian Federation), K. Levina (Tallinn, Estonia), M. Kütt (Tallinn, Estonia), I. Mokrousov (St. Petersburg, Russian Federation)
Source:
Virtual Congress 2020 – Multidrug-resistant tuberculosis
Session:
Multidrug-resistant tuberculosis
Session type:
E-poster session
Number:
1602
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Gerasimova (St. Petersburg, Russian Federation), A. Vyazovaya (St. Petersburg, Russian Federation), K. Levina (Tallinn, Estonia), M. Kütt (Tallinn, Estonia), I. Mokrousov (St. Petersburg, Russian Federation). Tuberculosis in Estonia: a major impact of Russian MDR Mycobacterium tuberculosis Beijing B0/W148-cluster. 1602
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
The Beijing genotype dominates the multidrug-resistant Mycobacterium tuberculosis population in North-West Russia
Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection
Year: 2021
Multidrug-resistant and extensively drug resistance tuberculosis has a strong public health and economical impact in the Republic of Moldova
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
Source: Eur Respir J 2012; 39: 1425-1431
Year: 2012
Mutations in the genes of drug-resistant mycobacterium tuberculosis in Uzbekistan
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014
High incidence of the Beijing strains among multi drug resistance isolates of Mycobacterium tuberculosis from extra pulmonary tuberculosis cases in northern India
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
Multidrug-resistant strains of M. tuberculosis circulated in penitentiary system in Kyrgyz Republic
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
Influence of mycobacterium tuberculosis strains on recurrence of tuberculosis in Hanoi, Vietnam
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
Determinants of multidrug-resistant tuberculosis (MDR-TB) in Belarus
Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview
Year: 2012
Tuberculosis 1995–2004: evaluation of the resistance of mycobacterium tuberculosis to anti-TBC drugs in Greece
Source: Eur Respir J 2006; 28: Suppl. 50, 589s
Year: 2006
Prevalence of the epidemic variants of the Mycobacterium tuberculosis Beijing genotype across Russian regions
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021
Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
The prevalence of the Beijing genotype
Mycobacterium tuberculosis
strains in Istanbul
Source: Eur Respir J 2005; 26: Suppl. 49, 191s
Year: 2005
XDR and MDR-TB genetic markers of M. tuberculosis strains circulating in Kyrgyz Republic
Source: Annual Congress 2011 - Challenges in tuberculosis control
Year: 2011
Genotypes of mycobacterium tuberculosis with pre-extended drug resistance in Belarus
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016
Childhood tuberculosis in Romania
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
Description of
M. tb
strains structure among new TB cases in Tomsk Oblast, Russia
Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB)
Year: 2006
Resistance genotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Serbia
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
Trends of multidrug-resistant tuberculosis clustering in Portugal
Source: ERJ Open Res, 5 (1) 00151-2018; 10.1183/23120541.00151-2018
Year: 2019
The global risk of dying from multidrug-resistant tuberculosis (MDR-TB)
Source: International Congress 2014 – Tuberculosis epidemiology: novel features
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept